News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lowinger Timothy B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/18/2023 |
4
| Lowinger Timothy B (SVP, Chief Sci.&Tech. Off.) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 6,233 shares
@ $5.74, valued at
$35.8k
Granted 168,750 options to buy
@ $6.06, valued at
$1M
Granted 37,500 restricted stock units
@ $0
Exercised 4,792 restricted stock units
@ $0
Exercised 7,292 restricted stock units
@ $0
Exercised 7,917 restricted stock units
@ $0 |
|
| 12/16/2022 |
4
| Lowinger Timothy B (SVP, Chief Sci.&Tech. Off.) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 11,111 options to buy
@ $1.4, valued at
$15.6k
Exercised 24,250 options to buy
@ $1.53, valued at
$37.1k
|
|
| 01/19/2022 |
4
| Lowinger Timothy B (Chief Science & Tech Off.) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 4,741 shares
@ $5.92, valued at
$28.1k
Exercised 7,917 restricted stock units
@ $0
Exercised 7,292 restricted stock units
@ $0
Granted 86,250 options to buy
@ $6.28, valued at
$541.7k
Granted 19,167 restricted stock units
@ $0 |
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Lowinger Timothy B (Chief Science & Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 7,775 shares
@ $12.47, valued at
$97k
Sold 8,496 shares
@ $12.02, valued at
$102.1k
Exercised 40,000 restricted stock units
@ $0 |
|
| 07/09/2021 |
4
| Lowinger Timothy B (CS & Technology Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $1.4, valued at
$28k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Lowinger Timothy B (Chief Science & Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 9,000 options to buy
@ $1.4, valued at
$12.6k
|
|
| 12/22/2020 |
4
| Lowinger Timothy B (Chief Science & Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 1,874 shares
@ $25.59, valued at
$48k
Sold 2,227 shares
@ $25.59, valued at
$57k
Sold 1,875 shares
@ $25.6, valued at
$48k
Sold 2,227 shares
@ $25.6, valued at
$57k
Exercised 1,874 options to buy
@ $3.51, valued at
$6.6k
Exercised 2,227 options to buy
@ $6.16, valued at
$13.7k
Exercised 1,875 options to buy
@ $3.51, valued at
$6.6k
|
|
| 10/22/2020 |
4
| Lowinger Timothy B (Chief Science & Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 1,875 shares
@ $16.74, valued at
$31.4k
Sold 2,227 shares
@ $16.74, valued at
$37.3k
Sold 1,874 shares
@ $17.5, valued at
$32.8k
Sold 2,227 shares
@ $17.5, valued at
$39k
Exercised 1,875 options to buy
@ $3.51, valued at
$6.6k
Exercised 2,227 options to buy
@ $6.16, valued at
$13.7k
Exercised 1,611 options to buy
@ $7.43, valued at
$12k
Exercised 15,240 options to buy
@ $1.4, valued at
$21.3k
Exercised 1,874 options to buy
@ $3.51, valued at
$6.6k
Exercised 2,227 options to buy
@ $6.16, valued at
$13.7k
|
|
| 09/23/2020 |
4
| Lowinger Timothy B (Chief Science, Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,749 shares
@ $20.6574, valued at
$77.4k
Sold 4,454 shares
@ $20.6574, valued at
$92k
Sold 12,411 shares
@ $20.6574, valued at
$256.4k
Exercised 3,749 options to buy
@ $3.51, valued at
$13.2k
Exercised 4,454 options to buy
@ $6.16, valued at
$27.4k
|
|
| 01/16/2020 |
4
| Lowinger Timothy B (Chief Science, Tech. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 142,500 options to buy
@ $6.16, valued at
$877.8k
Granted 31,667 restricted stock units
@ $0 |
|
| 07/19/2019 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 01/25/2019 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.51, valued at
$210.6k
|
|
| 09/25/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $11.63, valued at
$40.7k
Exercised 3,500 options to buy
@ $1.4, valued at
$4.9k
|
|
| 08/29/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $13.15, valued at
$46k
Exercised 3,500 options to buy
@ $7.43, valued at
$26k
|
|
| 07/25/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $11.06, valued at
$38.7k
|
|
| 07/05/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $1.4, valued at
$14k
|
|
| 02/23/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 5,911 options to buy
@ $6.98, valued at
$41.3k
|
|
| 02/06/2018 |
4
| Lowinger Timothy B (Chief Scientific Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 56,884 options to buy
@ $14.23, valued at
$809.5k
|
|
| 06/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|